BetterLife Pharma (BETRF) Amortization - Intangibles (2018 - 2022)

BetterLife Pharma's Amortization - Intangibles history runs 5 years deep, the most recent figure standing at $3641.5 for Q1 2022.

• In Q1 2022, Amortization - Intangibles fell 93.11% year-over-year to $3641.5; the TTM figure through Jan 2022 stood at $14720.2 (down 87.54% YoY), while the FY2023 annual figure was $14107.0, down 4.16% from the prior year.
• Amortization - Intangibles for Q1 2022 stood at $3641.5, down from $3666.2 in the prior quarter.
• The five-year high for Amortization - Intangibles was $243.3 billion in Q3 2018, with the low at -$408.9 billion in Q4 2018.
• The 5-year median for Amortization - Intangibles is $33584.2 (2020), against an average of -$11.0 billion.
• The sharpest annual moves came in 2019 and 2020: Amortization - Intangibles surged 114548.8% in 2019, then tumbled 102.61% in 2020.
• BetterLife Pharma's Amortization - Intangibles stood at -$408.9 billion in 2018, then soared by 100.0% to $187098.4 in 2019, then sank by 102.61% to -$4879.8 in 2020, then surged by 175.13% to $3666.2 in 2021, then declined by 0.67% to $3641.5 in 2022.
• Business Quant data shows BETRF's Amortization - Intangibles at $3641.5 in Q1 2022, $3666.2 in Q4 2021, and $3751.6 in Q3 2021.